Frohlich J, Fodor G, McPherson R, Genest J, Langner N
Healthy Heart Program, St Paul's Hospital, Vancouver, British Columbia.
Can J Cardiol. 1998 Apr;14 Suppl A:17A-21A.
A panel consisting of lipidologists, epidemiologists, cardiologists, internists, general practitioners, and public health and government representatives used the evidence-based approach to examine the rationale for a draft of recommendations for medical management of lipid disorders. The proposed recommendations deal with assessment of cardiovascular risk based on history, physical examination and laboratory findings; assessment of the fasting lipid profile; diagnosis and treatment of secondary risk factors; calculation of the 10-year risk of a cardiac event; initiation of lifestyle modifications in patients in whom low density lipoprotein cholesterol (LDL-C), total:high density lipoprotein cholesterol (HDL-C) ratio or triglycerides exceeds target values based on a patient's risk category; follow-up; treatment with drugs; and choices of drugs. In contrast to previous recommendations, there are new, considerably lower, cholesterol level targets for secondary prevention, with a less important emphasis on total cholesterol value than on LDL-C or total:HDL-C ratio and triglyceride levels, and an emphasis on determining the likelihood of a cardiac event by evaluating all relevant risk factors and sharpening the focus on nondrug treatment, which should result in treating a greater percentage of at-risk patients.
一个由脂质学家、流行病学家、心脏病学家、内科医生、全科医生以及公共卫生和政府代表组成的小组采用循证方法,审视了脂质异常疾病医学管理建议草案的依据。拟议的建议涉及基于病史、体格检查和实验室检查结果评估心血管风险;评估空腹血脂谱;诊断和治疗次要危险因素;计算心脏事件的10年风险;对于低密度脂蛋白胆固醇(LDL-C)、总胆固醇与高密度脂蛋白胆固醇(HDL-C)之比或甘油三酯超过基于患者风险类别设定的目标值的患者,启动生活方式改变;随访;药物治疗;以及药物选择。与先前的建议相比,二级预防有了新的、显著更低的胆固醇水平目标,对总胆固醇值的重视程度低于对LDL-C或总胆固醇与HDL-C之比及甘油三酯水平的重视程度,并且强调通过评估所有相关危险因素来确定心脏事件的可能性,并更加注重非药物治疗,这应该会使更大比例的高危患者得到治疗。